| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Gottlieb Scott is a Director at TEM, with reported holdings spanning 4 companies. Recent filings cover 6 purchases and 9 sales. Those positions are worth an estimated $4.5M at current prices.
Our model assigns Gottlieb Scott a below-average insider score of 41/100, based on 7 past trades. Over a 12-month horizon, 16.7% of those trades were profitable, with an average 12-month return of -12.7%.
Gottlieb Scott's largest disclosed position is in ILMN as Director, worth about $4.2M. Net of sales, the recent Form 4 record there shows accumulation of 700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | ILMN Illumina, Inc. | Director | Buy | 200 | $117.81 | $23,562.00 | +1.6% | +21.5% | - | |
| Nov 3, 2025 | ILMN Illumina, Inc. | Director | Buy | 500 | $122.13 | $61,065.00 | +4.2% | +17.6% | - | |
| Apr 1, 2025 | TEM Tempus Ai, Inc. | Director | Sell10b5-1 | 27,837 | $47.21 | $1,314,153.74 | -45.9% | +34.6% | -0.4% | |
| Mar 17, 2025 | TEM Tempus Ai, Inc. | Director | Sell10b5-1 | 27,838 | $48.85 | $1,359,988.91 | -31.5% | +44.4% | +1.9% | |
| Oct 30, 2024 | PFE Pfizer Inc | Director | Buy | 1,000 | $28.24 | $28,240.00 | +11.1% | -6.2% | -14.8% | |
| Dec 15, 2023 | PFE Pfizer Inc | Director | Buy | 3,000 | $26.47 | $79,401.00 | +50.0% | +5.6% | -3.9% | |
| May 8, 2023 | PFE Pfizer Inc | Director | Buy | 2,000 | $38.50 | $77,005.00 | +50.0% | -7.7% | -28.2% |